Danis RP - Search Results

1

Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases.

Danis RP, Henry SP, Ciulla TA. Danis RP, et al. Expert Opin Pharmacother. 2001 Feb;2(2):277-91. doi: 10.1517/14656566.2.2.277. Expert Opin Pharmacother. 2001. PMID: 11336586 Review.

2

Changing therapeutic paradigms in CMV retinitis in AIDS.

Piper H, Ciulla TA, Danis RP, Pratt LM. Piper H, et al. Among authors: danis rp. Expert Opin Pharmacother. 2000 Dec;1(7):1343-52. doi: 10.1517/14656566.1.7.1343. Expert Opin Pharmacother. 2000. PMID: 11249469 Review.

3

Anti-angiogenic therapy of proliferative diabetic retinopathy.

Danis RP, Ciulla TA, Criswell M, Pratt L. Danis RP, et al. Expert Opin Pharmacother. 2001 Mar;2(3):395-407. doi: 10.1517/14656566.2.3.395. Expert Opin Pharmacother. 2001. PMID: 11336594 Review.

4

Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization.

Danis R, Criswell M, Orge F, Wancewicz E, Stecker K, Henry S, Monia B. Danis R, et al. Curr Eye Res. 2003 Jan;26(1):45-54. doi: 10.1076/ceyr.26.1.45.14252. Curr Eye Res. 2003. PMID: 12789536

5

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

Ciulla TA, Criswell MH, Danis RP, Hill TE. Ciulla TA, et al. Among authors: danis rp. Arch Ophthalmol. 2001 Mar;119(3):399-404. doi: 10.1001/archopht.119.3.399. Arch Ophthalmol. 2001. PMID: 11231773

6

Transpupillary thermotherapy for subfoveal occult choroidal neovascularization: effect on ocular perfusion.

Ciulla TA, Harris A, Kagemann L, Danis RP, Maturi R, McNulty L, Pratt LM, Xiao M, Criswell MH, Weinberger D. Ciulla TA, et al. Among authors: danis rp. Invest Ophthalmol Vis Sci. 2001 Dec;42(13):3337-40. Invest Ophthalmol Vis Sci. 2001. PMID: 11726642

7

Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization.

Martidis A, Miller DG, Ciulla TA, Danis RP, Moorthy RS. Martidis A, et al. Among authors: danis rp. J Ocul Pharmacol Ther. 1999 Oct;15(5):425-8. doi: 10.1089/jop.1999.15.425. J Ocul Pharmacol Ther. 1999. PMID: 10530703

8

Comparison of intraocular to plasma HIV-1 viral burden in patients with cytomegalovirus retinitis.

Ciulla TA, Schnizlein-Bick CT, Danis RP, Frank MO, Wheat LJ. Ciulla TA, et al. Among authors: danis rp. Am J Ophthalmol. 1999 Feb;127(2):221-3. doi: 10.1016/s0002-9394(98)00345-6. Am J Ophthalmol. 1999. PMID: 10030574

9

Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.

Danis RP, Ciulla TA, Pratt LM, Anliker W. Danis RP, et al. Retina. 2000;20(3):244-50. Retina. 2000. PMID: 10872928 Clinical Trial.

10

Macular pigment optical density in a midwestern sample.

Ciulla TA, Curran-Celantano J, Cooper DA, Hammond BR Jr, Danis RP, Pratt LM, Riccardi KA, Filloon TG. Ciulla TA, et al. Among authors: danis rp. Ophthalmology. 2001 Apr;108(4):730-7. doi: 10.1016/s0161-6420(00)00655-2. Ophthalmology. 2001. PMID: 11297490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page